Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Daming Zhou, Helen M. E. Duyvesteyn, Cheng‐Pin Chen, Chung‐Guei Huang, Ting-Hua Chen, Shin‐Ru Shih, Yi‐Chun Lin, Chien‐Yu Cheng, Shu‐Hsing Cheng, Yhu‐Chering Huang, Tzou‐Yien Lin, Che Ma, Jiandong Huo, Loïc Carrique, Tomas Malinauskas, Reinis R. Ruza, Pranav N. M. Shah, Tiong Kit Tan, Pramila Rijal, Robert F. Donat, Kerry Godwin, Karen R. Buttigieg, Julia A. Tree, Julika Radecke, Neil G. Paterson, Piyada Supasa, Juthathip Mongkolsapaya, Gavin Screaton, Miles W. Carroll, Javier Gilbert‐Jaramillo, Michael L. Knight, William James, Raymond J. Owens, James H. Naismith, Alain Townsend, Elizabeth E. Fry, Yuguang Zhao, Jingshan Ren, David I. Stuart, Kuan-Ying A. Huang
Topics & Concepts
NeutralizationEpitopeTrimerAntibodyChemistrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GlycoproteinSpike (software development)Binding siteNeutralizing antibodyCoronavirusVirologyCoronavirus disease 2019 (COVID-19)Plasma protein bindingBiologyBiochemistryDimerGeneticsMedicineOrganic chemistryEconomicsInfectious disease (medical specialty)ManagementDiseasePathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing